Jounce Therapeutics, Inc. announced that Elizabeth Trehu, M.D., the company's chief medical officer, is expected to resign from her role at the company as of a date that was not determinable at the time of such disclosure.
Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |